2023 RCPATH ACHIEVEMENT AWARD WINNERS 🏆
Huge effort by NHS Lothian infection team to deliver the "Infection bootcamp" over past 2 years. Well deserved recognition of the team's hard work 🎉
@NCAS_Aus Journal Club. Thanks @simgalimam for discussing his local health networks implementation of antibiotic hard stops, the benefits of reducing #DOTs and #LOTs and potential consequences when not reviewed. Read full publication here: https://t.co/UnPuOQ5QfO
The official opening of the new and improved Junior Doctors mess at WGH today in Pentland Lodge. Thank you to all who made it happen especially our Chief Registrars and @NHSLothianMedEd team
I also have a related editorial with @ValerieVaughnMD that a lot of the environment we "swim" in hasn't been thoughtfully designed at all.
#HVMC2023
https://t.co/OoStIihmaH
“ACCEPT-UTI: Empirical use of piperacillin/tazobactam for ESBL UTIs showed no difference in clinical success outcomes compared to the empirical use of carbapenems”
Check out this study by @sylviastefanos et al:
https://t.co/iwWVqttzWf
@AthenaLVHobbs@SIDPharm#JACAMRNews
Found my poster! 📸
Outcome: 40% REDUCTION in antibiotic prophylaxis for recurrent UTI within Bridgend locality! That’s >2,200 fewer antibiotics per year.
#UTIFriday#BSACSpring2023
Fluoroquinolone antibiotics: reminder of measures to reduce the risk of long-lasting, disabling and potentially irreversible side effects | European Medicines Agency https://t.co/dddHTbmxrC via @EMA_News
From @dr_vpatel910; @BrianChuSF; @UPenn_Allergy: A penicillin allergy testing service assessed penicillin allergy in patients with hematologic malignancies. All tested patients were negative. Patients who were challenged passed and were delabeled.
📄https://t.co/FeO8FvSy62
Are you an early-stage clinician interested in haematological #infections? The #ICDhaem course in our Infection Clinical Dilemmas series explores the common infection issues in haemato-oncology patients and the best ways to manage them 🦠 Join now! 👇 https://t.co/1eJBYRqk6J
@ErinMcCreary giving us a unique argument for advocating IV to PO abx switch for serious infections ➡️ Saving massive amounts of nursing time! ⏰ (avg 22 min to administer IV vs. 80 seconds for PO) 🤯
@MAD_ID_ASP#MADID2023
@silentID3 @ABsteward But we don’t treat the infection in isolation and if that is your only focus we aren’t practising realistic safe holistic medicine.
"IV antibiotics hold some kind of “mythical status” for both the clinician and patient, especially when it comes to deeper infections like bacteremia and infective endocarditis.Mythology is, unfortunately, a poor proxy for data, but luckily evidence-based alternatives exist!"🎯
"Choosing the less safe, not more effective IV-only alternative may be akin to administering a proverbial “placebo” to treat the clinician’s or patient’s own anxiety"
Please RT